Clinical Research Directory
Browse clinical research sites, groups, and studies.
AZAHAR Study To Describe Anifrolumab in a Real-World Setting
Sponsor: AstraZeneca
Summary
AZAHAR is an observational retrospective and longitudinal study with adults patients with SLE who initiated treatment with anifrolumab from June 1, 2023 to May 31, 2024. The overall objective is to describe the characteristics and clinical outcomes of patients with SLE that initiated anifrolumab during its first year of commercialization in Spain.
Official title: AZAHAR Study. Observational Retrospective Study To Describe Characteristics And Clinical Outcomes of Patients With Systemic Lupus Erythematosus Initiating Saphnelo (Anifrolumab) in a Real-World Setting
Key Details
Gender
All
Age Range
18 Years - 130 Years
Study Type
OBSERVATIONAL
Enrollment
152
Start Date
2025-02-03
Completion Date
2025-06-05
Last Updated
2026-06-04
Healthy Volunteers
No
Conditions
Locations (13)
Research Site
Barcelona, Spain
Research Site
Granada, Spain
Research Site
Jaén, Spain
Research Site
L'Hospitalet de Llobregat, Spain
Research Site
León, Spain
Research Site
Madrid, Spain
Research Site
Málaga, Spain
Research Site
Mérida, Spain
Research Site
Móstoles, Spain
Research Site
Murcia, Spain
Research Site
Seville, Spain
Research Site
Toledo, Spain
Research Site
Valladolid, Spain